These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 8972028)
1. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5. Nakatanl S; Hato T; Minamoto Y; Fujita S Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028 [TBL] [Abstract][Full Text] [Related]
2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
3. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa. Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345 [TBL] [Abstract][Full Text] [Related]
5. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor. Barre DE Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375 [TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb. Naimushin YA; Mazurov AV Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313 [TBL] [Abstract][Full Text] [Related]
7. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation. Savi P; Zamboni G; Rescanières O; Herbert JM Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508 [TBL] [Abstract][Full Text] [Related]
8. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity. Jennings LK; White MM; Mandrell TD Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236 [TBL] [Abstract][Full Text] [Related]
9. Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa. Liu LX; Nardi MA; Nierodzik ML; Karpatkin S Br J Haematol; 1995 Dec; 91(4):976-82. PubMed ID: 8547151 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa. Mazurov AV; Khaspekova SG; Byzova TV; Tikhomirov OYu ; Berndt MC; Steiner B; Kouns WC FEBS Lett; 1996 Aug; 391(1-2):84-8. PubMed ID: 8706936 [TBL] [Abstract][Full Text] [Related]
11. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160 [TBL] [Abstract][Full Text] [Related]
12. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa. Tokita S; Arai M; Yamamoto N; Katagiri Y; Tanoue K; Igarashi K; Umeda M; Inoue K Thromb Haemost; 1996 Jan; 75(1):168-74. PubMed ID: 8713797 [TBL] [Abstract][Full Text] [Related]
13. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Mondoro TH; Wall CD; White MM; Jennings LK Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946 [TBL] [Abstract][Full Text] [Related]
14. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein. Shido K; Ahmad G; Hsu L; Kamiyama M J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587 [TBL] [Abstract][Full Text] [Related]
15. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length. Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688 [TBL] [Abstract][Full Text] [Related]
16. Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist. Cox D; Aoki T; Seki J; Motoyama Y; Yoshida K Thromb Haemost; 1996 Mar; 75(3):503-9. PubMed ID: 8701416 [TBL] [Abstract][Full Text] [Related]
17. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972 [TBL] [Abstract][Full Text] [Related]
18. Platelet-fibrinogen interactions. Bennett JS Ann N Y Acad Sci; 2001; 936():340-54. PubMed ID: 11460491 [TBL] [Abstract][Full Text] [Related]
19. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation. Sloan SM; Brown EB; Liu Q; Frojmovic MM Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888 [TBL] [Abstract][Full Text] [Related]
20. "Bridged" peptide of fibrinogen binds to platelets activated by RGD peptide as well as by ADP. Mohri H; Ohkubo T Peptides; 1994; 15(4):683-7. PubMed ID: 7937346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]